Prospective study on the diagnosis and prognosis of lung cancer by using new simultaneously observed seromarkers.
Institute of Cancer Prevention and Therapy, Shanghai Fangshan Hospital, People's Republic of China.
Q
Q
Zhang
H
H
Ren
B
B
Wang
D000230:Adenocarcinoma / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000473:pathology; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D002277:Carcinoma / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D012016:Reference Values; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor